Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities

We have previously shown that combination of foretinib, an inhibitor of MET (hepatocyte growth factor receptor), with gefitinib or lapatinib, inhibitors of EGFR (epidermal growth factor receptor), has a synergistic cytotoxic effect on melanoma cells. However, there are cancer cells resistant to drug...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Simiczyjew, Aleksandra, Pietraszek-Gremplewicz, Katarzyna, Dratkiewicz, Ewelina, Podgórska, Marta, Matkowski, Rafał, Ziętek, Marcin, Nowak, Dorota
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6792435/
https://ncbi.nlm.nih.gov/pubmed/31649529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados